Sands Capital Ventures
Venture capital · Arlington, Virginia, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
5Deep-tech portfolio2 active
3Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Avenzo Therapeutics
9Co-investorsShare a portfolio company
Portfolio · 5 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Avenzo Therapeutics | Biotech | Active | Sep 5, 2025 | $78.7M |
| Adcendo | Biotech | Active | — | — |
| BioAge Labs | Biotech | Public | Feb 13, 2024 | $194.4M |
| Freenome | Medtech | Public | Oct 28, 2015 | $800K |
| Illumina | Medtech | Public | — | — |
Peer ranks
Portfolio size#81
Portfolio exits#69
Raises, 12 months#88
Co-investors#165
Co-investors
- OrbiMedVenture capital2 shared
- Venrock Healthcare Capital PartnersVenture capital2 shared
- Andreessen HorowitzVenture capital1 shared
- GVVenture capital1 shared
- Jeito CapitalVenture capital1 shared
- Khosla VenturesVenture capital1 shared
- RA CapitalVenture capital1 shared
- Sofinnova VenturesVenture capital1 shared
- TCG CrossoverVenture capital1 shared
Sectors
- Biotech3
- Medtech2
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.